Parallax Volatility Advisers’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Parallax Volatility Advisers’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-310,000	Closed	-$6.61M	–	2334
2024 Q1	$6.61M	Buy	+310,000	New	+$3.71M	0.01%	637

Parallax Volatility Advisers's FUSN Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 36,659 shares — an estimated $782K sold.

Parallax Volatility Advisers first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $782K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Parallax Volatility Advisers reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 36,659 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $782K.
Parallax Volatility Advisers first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Parallax Volatility Advisers's Fusion Pharmaceuticals Inc. Common Shares position peaked at $782K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.